Effects of prenatal AZT on mouse neurobehavioral development and passive avoidance learning

Neurotoxicology and Teratology

Volumn 21, Issue 1, 1999, Pages 29-40

  Calamandrei, Gemma ^a   Venerosi, Aldina ^a   Branchi, Igor ^a   Chiarotti, Flavia ^a   Verdina, Alessandra ^b   Bucci, Federica ^b   Alleva, Enrico ^a  

^a Lab Fisiopatol Organo Sistema   (Italy)

^b Laboratorio di Biochimica Clinica   (Italy)

Author keywords

AIDS; AZT; Maternal infant transmission; Mouse; Neurobehavioral development; Zidovudine

Indexed keywords

ZIDOVUDINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT DISORDER; CONTROLLED STUDY; DELIVERY; DRUG EFFECT; FEMALE; FETUS; FETUS DEVELOPMENT; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NONHUMAN; ORAL DRUG ADMINISTRATION; PASSIVE AVOIDANCE; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; REFLEX; SEX DIFFERENCE;

AGONISTIC BEHAVIOR; ANIMALS; ANTI-HIV AGENTS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; MALE; MEMORY; MICE; MOTOR ACTIVITY; NERVOUS SYSTEM; PREGNANCY; SEX CHARACTERISTICS; SOCIAL BEHAVIOR; ZIDOVUDINE;

ANIMALIA;

EID: 0032969702     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0892-0362(98)00035-X     Document Type: Article

References (40)

1. Alleva E. Assessment of aggressive behavior in rodents. Methods Neurosci. 14:1993;111-137.
2. Alleva E., Bignami G. Development of mouse activity, stimulus reactivity, habituation, and response to amphetamine and scopolamine. Physiol. Behav. 34:1985;519-523.
3. Alleva E., Laviola G., Tirelli E., Bignami G. Short-, medium-, and long-term effects of prenatal oxazepam on neurobehavioral development of mice. Psychopharmacology (Berlin). 87:1985;434-441.
4. Bigi S., De Acetis L., De Simone R., Aloe L., Alleva E. Neonatal capsaicin exposure affects isolation-induced aggressive behavior and hypothalamic substance P levels of adult male mice (Mus musculus). Behav. Neurosci. 107:1993;363-369.
5. Bignami G., Musi B., Dell'Omo G., Laviola G., Alleva E. Limited effects of ozone exposure during pregnancy on physical and neurobehavioral development of CD-1 mice. Toxicol. Pharmacol. 129:1994;264-271.
6. Blanche S., Rouzioux C., Guthard Moscato M.-L., Veber F., Mayaux M.-J., Jacomet C., Tricoire J., Deville A., Vial M., Firtion G., de Crepy A., Douard D., Robin M., Courpotin C., Ciraru-Vigneron N., le Deist F., Griscelli C. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N. Engl. J. Med. 320:1989;1643-1648.
7. Blum R.M., Liao S.H.T., Good S.S., de Miranda P. Pharmacokinetics and bioavailability of zidovudine in humans. Am. J. Med. 85:1988;189-194.
8. Calamandrei G., Alleva E. Epidermal growth factor has both growth-promoting and growth-inhibiting effects on physical and neurobehavioral development of neonatal mice. Brain Res. 477:1989;1-6.
9. Calamandrei G., Ricceri L., Valanzano A. Neonatal cocaine alters behavioural responsiveness to scopolamine and cholinergic development in mice. Pharmacol. Biochem. Behav. 56:1997;557-563.
10. Calamandrei G., Ricceri L., Valanzano A. Systemic administration of anti-NGF antibodies to neonatal mice impairs 24-h retention of an inhibitory avoidance task while increasing ChAT immunoreactivity in the medial septum. Behav. Brain Res. 78:1996;81-91.
11. Calamandrei G., Wilkinson L.S., Keverne E.B. Olfactory recognition of infants in laboratory mice. Role of noradrenergic mechanisms Physiol. Behav. 52:1992;901-907.
12. Connor E.M., Sperling R.S., Gelber R., Kiselev P., Scott G., O'Sullivan M.J., VanDyke R., Bey M., Shearer W., Jacobson R.L., Jimenez E., O'Neill E., Bazin B., Delfraissy J.-F., Culnane M., Coombs R., Elkins M., Moye J., Stratton P., Balsley J. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N. Engl. J. Med. 331:1994;1173-1180.
13. Fox W.M. Reflex-ontogeny and behavioral development of the mouse. Anim. Behav. 13:1965;234-240.
14. Frenkel L.M., Wagner L.E. II, Demeter L.M., Dewhurst S., Coombs R.W., Murante B.L., Reichman R.C. Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1. Clin. Infect. Dis. 20:1995;1321-1326.
15. Gogu S.R., Beckman B.S., Agrawar K.C. Ameloration of zidovudine-induced fetal toxicity in pregnant mice. Antimicrob. Agent Chemother. 36:1992;2320-2374.
16. Grant E.C., Mackintosh J.H. A comparison of the social postures of some common laboratory rodents. Behavior. 21:1963;246-259.
17. Greene J.A., Ayers K.M., Tucker W.E. Jr., de Miranda P. Nonclinical toxicology studies with zidovudine. Reproductive toxicity studies in rats and rabbits Fundam. Appl. Toxicol. 32:1996;140-147.
18. Ha J.C., Nobisch C., Conrad S.H., Ruppenthal G.C., Sackett G.P., Abkowitz J., Unadkat J.D. Fetal toxicity of zidovudine (azidothimidine) in Macaca nemestrina. Preliminary observations J. Acquir. Immune Defic. Syndr. 7:1994;154-157.
19. Huang C.S.-H., Boudinot F.D., Feldman S. Maternal-fetal pharmocokinetics of zidovudine in rats. J. Pharmaceutic. Sci. 85:1996;965-970.
20. Matochik J.A., Sipos M.L., Nyby J.G., Barfield R.J. Intracranial androgenic activation of male-typical behaviors in house mice. Motivation versus performace Behav. Brain Res. 60:1994;41-49.
21. Morse D.E., Davis H.D., Popke E.J., Brown K.J., O'Donoghue V.A., Grunberg N.E. Effects of ddC and AZT on locomotion and acoustic startle I. Acute effects in female rats Pharmacol. Biochem. Behav. 56:1997;221-228.
22. Noldus L.P.J.J. The Observer. A software system for collection and analysis of observational data Behav. Res. Methods Instrum. Comp. 23:1991;415-429.
23. Petruzzi S., Fiore M., Dell'Omo G., Bignami G., Alleva E. Medium and long-term behavioral effects in mice of extended gestational exposure to ozone. Neurotoxicol. Teratol. 17:1995;463-470.
24. Raum W.J., McGivern R.F., Peterson M.A., Shryne J.H., Gorski R.A. Prenatal inhibition of hypothalamic sex steroid uptake by cocaine. Effects on neurobehavioural sex differentiation in male rats Dev. Brain Res. 53:1990;230-236.
25. Rugh R. The mouse. Its reproduction and development. 1990;Oxford University Press, Oxford. 38-39.
26. Ruprecht R.M., O'Brien L.G., Rossoni L.D., Nusinoff-Lehrman S. Suppression of mouse viraemia and retroviral disease by 3′-azido-3′deoxythymidine. Nature. 323:1986;467-469.
27. Sharpe A.H., Hunter J.J., Ruprecht R.M., Jaenisch R. Maternal transmission of retroviral disease and strategies for preventing infection of the neonate. J. Virol. 63:1989;1049-1053.
28. Sharpe A.H., Jaenisch R., Ruprecht R.M. Retroviruses and mouse embryos. A rapid model for neurovirulence and transplacental antiviral therapy Science. 263:1987;1671-1674.
29. Sieh E., Coluzzi M.L., Cusella De Angelis M.G., Mezzogiorno A., Floridia M., Canipari R., Cossu G., Vella S. The effects of AZT and ddI on pre- and postimplantation mammalian embryos. An in vivo and in vitro study AIDS Res. Hum. Retroviruses. 8:1992;639-649.
30. Sikka C.S., Gogu S.R., Agrawal K.C. Effect of zidovudine (AZT) on reproductive and hematopoietic system in the male rat. Biochem. Pharmacol. 42:1991;1293-1297.
31. Spear L.P., Kirstein C.L., Frambes N.A. Cocaine effects on the developing central nervous system. Behavioural psychopharmacological, and neurochemical studies Ann. NY Acad. Sci. 562:1989;290-307.
32. Sperling R.S., Stratton P., O'Sullivan M.J., Boyer P., Watts D.H., Lambert J.S., Hammill H., Livingston E.G., Gloeb D.J., Minkoff H., Fox H.E. A survey of zidovudine use in pregnant women with human immunodeficiency virus infection. N. Engl. J. Med. 326:1992;857-861.
33. St. Louis M.E., Kamenga M., Brown C., Nelson A.M., Manzila T., Batter V., Behets F., Kabagabo U., Ryder R.W., Oxtoby M, Quinn T.C., Heyward W.L. Risk for perinatal HIV-1 trasmission according to maternal immunologic, virologic, and placental factors. JAMA. 269:1993;2853-2859.
34. Taylor L., Gorman J.M., Givon L. The effect of prepartum zidovudine administration on the physical and behavioral development of mice. Pediatric AIDS and HIV Infect. Fetus to Adolescent. 3:1992;308-312.
35. Terranova M.L., Laviola G., Alleva E. Ontogeny of amicable social behavior in the mouse. Gender differences and ongoing isolation outcomes Dev. Psychobiol. 26:1993;467-481.
36. Toltzis P., Marx C.M., Kleinman N., Levine E.M., Schmidt E.V. Zidovudine-associated embryonic toxicity in mice. J. Infect. Dis. 163:1991;1212-1218.
37. Toltzis P., Mourton T., Magnuson T. Effect of zidovudine on preimplantation murine embryos. Antimicrob. Agents Chemother. 37:1993;1610-1613.
38. Vorhees C.V. Principles in neurobehavioral teratology. Riley E.P., Vorhees C.V. Handbook of behavioral teratology. 1986;23-48 Plenum Press, New York/London.
39. Van Oortmerssen G.A. Biological significance, genetics and evolutionary origin of variability in behavior within and between inbred strains of mice (Mus musculus). Behaviour. 6:1971;35-65.
40. Wilcox R.R. New statistical procedures for the social sciences. Modern solutions to basic problems. 1987;Lawrence Erlbaum, Hillsdale, NJ.